It is the latest in a sequence of FDA actions tightening the legal space around compounded GLP-1s
Sano Y, Tanaka S, Kudo SE, Saito S, Matsuda T, Wada Y, Fujii T, Ikematsu H, Uraoka T, Kobayashi N, Nakamura H, Hotta K, Horimatsu T, Sakamoto N, Fu KI, Tsuruta O, Kawano H, Kashida H, Takeuchi Y, Machida H, Kusaka T, Yoshida N, Hirata I, Terai T, Yamano HO, Kaneko K, Nakajima T, Sakamoto T, Yamaguchi Y, Tamai N, Nakano N, Hayashi N, Oka S, Iwatate M, Ishikawa H, Murakami Y, Yoshida S, Saito Y (2016) Narrow-band imaging (NBI) magnifying endoscopic classification of colorectal tumors proposed by the Japan NBI Expert Team
While this study offers valuable insights, it also underscores the need for further research to explore additional outcomes beyond weight loss
Glucagon opposes insulin action, which creates a more complex interaction profile with diabetic medications
The liposomal form protects the active ingredient from the the stomach acidity and enhence the intestinal absorption